NCT03813862 Observational Pharmaco-Epidemiology Research & Analysis
| NCT ID | NCT03813862 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Epividian |
| Condition | Chronic Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000,000 participants |
| Start Date | 2013-12-01 |
| Primary Completion | 2035-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000,000 participants in total. It began in 2013-12-01 with a primary completion date of 2035-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient care, population management and disease management; and 2) the use of the point-of-care observational data from the provider-patient encounter that support realworld medical research and healthcare quality measure assessment. Real-world evaluations of treatments of chronic diseases in the context of comorbid conditions and special populations (minorities, women, mentally ill, and those with addiction) are limited. The purpose of the OPERA database is to help address this unmet need in clinical research.
Eligibility Criteria
Inclusion Criteria: * Patients who are treated in the practices who enroll and participate in the study * Patients whose treatment is documented in the practice's electronic health record system Exclusion Criteria: * Patients who opt out of OPERA
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03813862 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, studying Chronic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03813862 currently recruiting?
Yes, NCT03813862 is actively recruiting participants. Contact the research team at gregory.fusco@epividian.com for enrollment information.
Where is the NCT03813862 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT03813862 clinical trial?
NCT03813862 is sponsored by Epividian. The trial plans to enroll 2,000,000 participants.